At Home With Art
Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art
Krishna Gopalan - August 19, 2017
Managing Growth 2017- Part 2
Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal
March 17, 2017
Managing Growth 2017- Part 1
CEOs from diverse sectors on what's in store for 2017
March 17, 2017
Cash-rich picks in the current market
Looking for cash bargains? Here is a first cut list
Jitendra Kumar Gupta - August 26, 2015
Wind beneath his wings
India's most reticent billionaire is betting his money on the alternative energy space and here's why
Krishna Gopalan - May 05, 2015
Will Sun rise again?
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
Kripa Mahalingam - June 15, 2015
Critical condition
Drug majors are shifting clinical trials out of India as lawmakers turn on the heat
Kripa Mahalingam - June 17, 2015
The other shoe drops
It took Reebok India five years to wake up to financial irregularities of nearly ₹900 crore. What happens now?
Krishna Gopalan - December 14, 2015
